Literature DB >> 10074208

Ebola virus selectively inhibits responses to interferons, but not to interleukin-1beta, in endothelial cells.

B H Harcourt1, A Sanchez, M K Offermann.   

Abstract

Ebola virus infection is highly lethal and leads to severe immunosuppression. In this study, we demonstrate that infection of human umbilical vein endothelial cells (HUVECs) with Ebola virus Zaire (EZ) suppressed basal expression of the major histocompatibility complex class I (MHC I) family of proteins and inhibited the induction of multiple genes by alpha interferon (IFN-alpha) and IFN-gamma, including those coding for MHC I proteins, 2'-5' oligoadenylate synthetase [2'-5'(A)N], and IFN regulatory factor 1 (IRF-1). Induction of interleukin-6 (IL-6) and ICAM-1 by IL-1beta was not suppressed by infection with EZ, suggesting that the inhibition of IFN signaling is specific. Gel shift analysis demonstrated that infection with EZ blocked the induction by IFNs of nuclear proteins that bind to IFN-stimulated response elements, gamma activation sequences, and IFN regulatory factor binding site (IRF-E). In contrast, infection with EZ did not block activation of the transcription factor NF-kappaB by IL-1beta. The events that lead to the blockage of IFN signaling may be critical for Ebola virus-induced immunosuppression and would play a role in the pathogenesis of Ebola virus infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10074208      PMCID: PMC104118     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

Review 1.  The war against the interferon-induced dsRNA-activated protein kinase: can viruses win?

Authors:  M G Katze
Journal:  J Interferon Res       Date:  1992-08

2.  [The immunogenic properties of Marburg virus proteins].

Authors:  A P Agafonov; G M Ignat'ev; V A Kuz'min; Z L Akimenko; T V Kosareva; E A Kashentseva
Journal:  Vopr Virusol       Date:  1992 Jan-Feb

Review 3.  Adenovirus proteins and MHC expression.

Authors:  S Pääbo; L Severinsson; M Andersson; I Martens; T Nilsson; P A Peterson
Journal:  Adv Cancer Res       Date:  1989       Impact factor: 6.242

4.  Association of Ebola-related Reston virus particles and antigen with tissue lesions of monkeys imported to the United States.

Authors:  T W Geisbert; P B Jahrling; M A Hanes; P M Zack
Journal:  J Comp Pathol       Date:  1992-02       Impact factor: 1.311

5.  Induction of intercellular adhesion molecule 1 gene expression by measles virus in human umbilical vein endothelial cells.

Authors:  B H Harcourt; P A Rota; K B Hummel; W J Bellini; M K Offermann
Journal:  J Med Virol       Date:  1999-01       Impact factor: 2.327

6.  IL-1 stimulates IL-6 production in endothelial cells.

Authors:  M Sironi; F Breviario; P Proserpio; A Biondi; A Vecchi; J Van Damme; E Dejana; A Mantovani
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

7.  Ebola haemorrhagic fever in Zaire, 1976.

Authors: 
Journal:  Bull World Health Organ       Date:  1978       Impact factor: 9.408

8.  Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire.

Authors:  K M Johnson; J V Lange; P A Webb; F A Murphy
Journal:  Lancet       Date:  1977-03-12       Impact factor: 79.321

9.  Marburg virus infection in monkeys. Ultrastructural studies.

Authors:  F A Murphy; D I Simpson; S G Whitfield; I Zlotnik; G B Carter
Journal:  Lab Invest       Date:  1971-04       Impact factor: 5.662

10.  Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola).

Authors:  S P Fisher-Hoch; G S Platt; G H Neild; T Southee; A Baskerville; R T Raymond; G Lloyd; D I Simpson
Journal:  J Infect Dis       Date:  1985-11       Impact factor: 5.226

View more
  45 in total

1.  Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence.

Authors:  Graham Simmons; Rouven J Wool-Lewis; Frédéric Baribaud; Robert C Netter; Paul Bates
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  The Ebola virus VP35 protein functions as a type I IFN antagonist.

Authors:  C F Basler; X Wang; E Mühlberger; V Volchkov; J Paragas; H D Klenk; A García-Sastre; P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

3.  Morphology and infectivity of virus that persistently caused infection in an AGS cell line.

Authors:  Yukimasa Ooi; Eriko Daikoku; Hong Wu; Hiroaki Aoki; Chizuko Morita; Takashi Nakano; Takehiro Kohno; Tomohiko Takasaki; Kouichi Sano
Journal:  Med Mol Morphol       Date:  2011-12-17       Impact factor: 2.309

4.  The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR.

Authors:  Zongdi Feng; Melissa Cerveny; Zhipeng Yan; Bin He
Journal:  J Virol       Date:  2006-10-25       Impact factor: 5.103

5.  Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression.

Authors:  Christopher R Kimberlin; Zachary A Bornholdt; Sheng Li; Virgil L Woods; Ian J MacRae; Erica Ollmann Saphire
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

6.  Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1.

Authors:  St Patrick Reid; Charalampos Valmas; Osvaldo Martinez; Freddy Mauricio Sanchez; Christopher F Basler
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

7.  Ebolavirus VP24 binding to karyopherins is required for inhibition of interferon signaling.

Authors:  Mathieu Mateo; St Patrick Reid; Lawrence W Leung; Christopher F Basler; Viktor E Volchkov
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

8.  Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis.

Authors:  Nadia Wauquier; Pierre Becquart; Cindy Padilla; Sylvain Baize; Eric M Leroy
Journal:  PLoS Negl Trop Dis       Date:  2010-10-05

9.  Discovery of common marburgvirus protective epitopes in a BALB/c mouse model.

Authors:  Warren V Kalina; Kelly L Warfield; Gene G Olinger; Sina Bavari
Journal:  Virol J       Date:  2009-08-27       Impact factor: 4.099

10.  Marburg virus evades interferon responses by a mechanism distinct from ebola virus.

Authors:  Charalampos Valmas; Melanie N Grosch; Michael Schümann; Judith Olejnik; Osvaldo Martinez; Sonja M Best; Verena Krähling; Christopher F Basler; Elke Mühlberger
Journal:  PLoS Pathog       Date:  2010-01-15       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.